IP Library Granted Patent US 11,293,008
Granted Patent B2
US 11,293,008 · App. 15/762,517 · Granted Apr 5, 2022

Media for culturing epithelial cells

Inventors: Mark A. LaBarge (Orinda, CA); Martha R. Stampfer (Oakland, CA); James C. Garbe (San Francisco, CA)
Assignee: The Regents of the University of California
C12N5/0631C12N2500/14C12N2500/32C12N2500/34C12N2500/35C12N2500/38C12N2500/46C12N2500/60
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,293,008
App. No.
15/762,517
Granted
Apr 5, 2022
Kind
B2
Abstract

A method of growing primary human epithelial cells, in particular human epithelial cells using a basal formula containing individual (a) amino acids, (b) vitamins, (c) trace elements, and (d) other organics such as linoleic acid. The basal medium may be a mixture of amino acids, vitamins, and salts that constitute the basic media that is used to culture epithelial cells over a number of population doublings, e.g., over at least one week, while maintaining a normal phenotype and exerting low stress on the cultured cells, and maintaining lineage heterogeneity.

Claims (24)

1. A basal medium, useful for low stress culture of normal human mammary epithelial cells (HMECs), comprising a 1× dilution of each of:

(a) a 100× solution comprising: 10.5 g/L±10% L-arginine hydrochloride, 7.88 g/L±10% L-Asparagine H 2 O, 1.147 g/L±10% Choline chloride, 2.622 g/L±10% L-Histidine HCl, 3.38 g/L±10% L-isoleucine (allo-free), 4.92 g/L±10% L-Leucine, 6.39 g/L±10% L-Lysine HCL, 1.086 g/L±10% L-Methionine, 2 g/L±10% L-Phenylalanine, 1.15 g/L±10% L-Proline, 2.89 g/L±10% L-Serine, 4.46 g/L±10% L-Threonine, 0.757 g/L±10% L-Tryptophan, 0.453 g/L±10% L-Tyrosine, 2.79 g/L±10% L-Tyrosine Disodium Salt Dihydrate, 4.4 g/L±10% L-Valine, and;

(b) a 100× solution comprising 0.5 mg/L±10% d-Biotin, 0.133 g/L±10% folinic acid (Ca2+ salt), 0.3 mg/L±10% folic acid, 0.407 g/L±10% Niacinamide, 0.124 g/L±10% Pantothenic Acid (Hemi-calcium salt), 0.103 g/L±10% Pyridoxine HCl, 0.126 g/L±10% Thiamine HCl, 0.041 g/L±10% Vitamin B12;

(c) a 100× solution comprising 32.86 g/L±10% L-Glutamine;

(d) a 100× solution comprising 8.25 g/L±10% sodium pyruvate;

(e) a 100× solution comprising 1.5 g/L±10% L-Cysteine HCl H 2 O

(f) a 100× solution comprising 0.668 g/L±10% L-Alanine, 0.998 g/L±10% L-Aspartic acid, 1.103 g/L±10% L-Glutamic acid, 1.312 g/L±10% Glycine;

(g) a 100× solution comprising 0.00675 g/L±10% adenine, 1.5 g/L±10% myo-inositol, 0.00535 g/L±10% Lipoic Acid, 0.022 g/L±10% thymidine, 0.004 g/L±10% putrescine 2HCl;

(h) a 200× solution of 41.06 g/L±10% CaCl 2 ) 2H 2 O;

(i) a 200× solution of 44.54 g/L±10% MgSO 4 7H 2 O;

(j) a 200× solution of 0.1807 g/L±10%, FeSO 4 7H 2 O;

(k) a 100× solution comprising 0.077 mg/L±10% CuSO 4 5H 2 O, 0.19 mg/L±10% H 2 SeO 3 , 0.006 mg/L±10% MnSO 4 5H 2 O, 0.71 g/L±10% NaSiO 3 9 H 2 O, 0.062 mg/L±10% (NH 4 )MO 7 O 24 4H 2 O, 0.0293 mg/L±10% NH 4 VO 3 , 0.00006 mg/L±10% NiCl 2 6H 2 O, 0.0000564 mg/L±10% SnCl 2 2H 2 O, and 0.029 g/L±10% ZnSO 4 7H 2 O; and

(l) a 100× solution of 0.0166 g/L±10% riboflavin,

wherein the basal medium supports growth of human mammary epithelial cells (HMECs) as pre-stasis finite cells for up to 60 population doublings.

2. The basal medium of claim 1 , further comprising HEPES buffer, NaOH, and D-glucose.

3. An optimized cell culture medium, comprising:

the basal medium of claim 1 ; and

serum, a growth factor, or both.

4. The optimized medium of claim 3 , comprising serum and a growth factor.

5. A method of making the basal medium according to claim 1 , the method comprising combining stock solutions (a)-(l) with water in a container to produce the basal medium comprising a 1× dilution of the stock solutions (a)-(l).

6. The method according to claim 5 , further comprising, after the combining, sterilizing the basal medium.

7. The basal medium of claim 1 , wherein the medium is free of conditioned medium.

8. A method for culturing epithelial cells, comprising the step of culturing the normal human epithelial cells with a culture medium comprising the basal medium according to claim 1 , for a period of time over which at least 10 population doublings of the normal HMECs occurs during the culturing.

9. The basal medium of claim 1 , further comprising normal human mammary epithelial cells (HMECs).

Assignments (2)
CONFIRMATORY LICENSE Recorded Apr 27, 2020
From: UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB
To: UNITED STATES DEPARTMENT OF ENERGY
Reel/Frame 052499/0363 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 25, 2018
From: LABARGE, MARK A.; STAMPFER, MARTHA R.; GARBE, JAMES C.
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 046965/0628 →
Continuity (2)
Provisional Application 62232294 · Sep 24, 2015
Related Publication 20190352606A1 · Nov 21, 2019